M.G. Jannuzzo

Randomized phase <scp>II</scp> study of danusertib in patients with metastatic castration‐resistant prostate cancer after docetaxel failure

Hielke J. Meulenbeld, Jean Pierre Bleuse, Elio M. Vinci et al. · British Journal of Urology · 2012 · 76 citations

Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study

P. Schöffski, Benjamin Besse, Thomas Gauler et al. · Annals of Oncology · 2014 · 55 citations · Full text

Non-small-cell Lung Cancer, Biweekly I.v, Medicine +9

High-performance liquid chromatographic method for pharmacokinetic studies on the new anthracycline 4-demethoxydaunorubicin and its 13-dihydro derivative

E. Moro, V. Bellotti, M.G. Jannuzzo et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1983 · 44 citations

Pharmacokinetic Studies, Medicinal Chemistry, Pharmaceutical Science +11

A predictive model for exemestane pharmacokinetics/pharmacodynamics incorporating the effect of food and formulation

Marta Valle, E. Di Salle, M.G. Jannuzzo et al. · British Journal of Clinical Pharmacology · 2005 · 42 citations · Full text

Pharmacokinetics of Single‐Dose Reboxetine in Volunteers with Renal Insufficiency

François Coulomb, Françis Ducret, J P Laneury et al. · The Journal of Clinical Pharmacology · 2000 · 30 citations